1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Andrew Long, PharmD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi OIT to Test Immune Markers After Minimum Maintenance Dose Omalizumab, Food Flour Allergens - Food Allergy | Phase 2 | Completed | Andrew Long, PharmD | 60 | 2017-07-31 | 2026-04-27 |
Omalizumab (1)
United States (1)